1. Home
  2. JKS vs IVA Comparison

JKS vs IVA Comparison

Compare JKS & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JinkoSolar Holding Company Limited (each representing 4)

JKS

JinkoSolar Holding Company Limited (each representing 4)

HOLD

Current Price

$14.91

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$4.46

Market Cap

883.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JKS
IVA
Founded
2006
2011
Country
China
France
Employees
N/A
77
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
883.8M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
JKS
IVA
Price
$14.91
$4.46
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$24.80
$16.20
AVG Volume (30 Days)
668.3K
1.4M
Earning Date
04-29-2026
03-30-2026
Dividend Yield
6.04%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$14.60
$751.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.95
$2.94
52 Week High
$31.88
$7.98

Technical Indicators

Market Signals
Indicator
JKS
IVA
Relative Strength Index (RSI) 34.10 54.91
Support Level N/A $3.96
Resistance Level $26.61 $4.69
Average True Range (ATR) 0.82 0.31
MACD 0.17 0.04
Stochastic Oscillator 7.42 70.41

Price Performance

Historical Comparison
JKS
IVA

About JKS JinkoSolar Holding Company Limited (each representing 4)

JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), the Americas, Europe, Asia Pacific, and the Rest of the world.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.

Share on Social Networks: